Maksoud J G, Chapchap P, Porta G, Miura I, Carone Filho E, Tannuri U, da Silva M M, Ayoub A A, Santos M M, Fauza D de O
Inst. da Criança Prof. Pedro de Alcântara do Hosp. das Clín., Fac. de Med. da Univ. de São Paulo.
AMB Rev Assoc Med Bras. 1991 Oct-Dec;37(4):193-9.
The initial experience at the Instituto da Criança do Hospital das Clínicas--School of Medicine of São Paulo University with liver transplantation in children is presented. A staff experienced in the management of children, including pediatric surgeons, hepatologists, critical care specialists, anesthesiologists, and other has been joined to draw therapeutic protocols. Afterward, more than 100 experimental liver transplant were performed in animals of medium size (dogs and pigs). From September, 1989 to July 1991, 12 liver transplants were performed on 9 children (3 retransplants) ranging in age from 2.5 to 17 years, being 5 boys and 4 girls. The donors had been selected according to the ABO blood group and body weight. Just once a blood A+ recipient received a liver from a blood O+ donor. The regular postoperative immunosuppression consisted of triple therapy with cyclosporin, prednisone and azathioprine. The postoperative stay in the Intensive Care Unit ranged from 3 to 24 days, according to the necessity of ventilatory support. These was no intraoperative mortality, arterial or venous thromboses, or early biliary complications. The overall survival is 78% (7/9). Primary non-function of the graft was the cause of death in two of our children. Although the number of cases is still small our results are comparable to those of the best liver transplant centers in the world.
本文介绍了圣保罗大学医学院儿童医院(Instituto da Criança do Hospital das Clínicas)在儿童肝移植方面的初步经验。一个由小儿外科医生、肝病学家、重症监护专家、麻醉师等儿童管理方面经验丰富的团队共同制定了治疗方案。此后,对中型动物(狗和猪)进行了100多次实验性肝移植。1989年9月至1991年7月,对9名年龄在2.5至17岁之间的儿童(3例再次移植)进行了12例肝移植,其中5名男孩,4名女孩。供体根据ABO血型和体重进行选择。只有一次,一名A+血型的受者接受了O+血型供体的肝脏。常规术后免疫抑制采用环孢素、泼尼松和硫唑嘌呤三联疗法。根据通气支持的需要,术后在重症监护病房的停留时间为3至24天。没有术中死亡、动脉或静脉血栓形成或早期胆道并发症。总体生存率为78%(7/9)。两名儿童的死亡原因是移植物原发性无功能。尽管病例数量仍然很少,但我们的结果与世界上最好的肝移植中心相当。